The US Food and Drug Administration (FDA) is seeking input on how to regulate next-generation sequencing (NGS) tests that can scan a tumor's genes to guide cancer treatments. At a public workshop at ...

This enables next-day reporting and greater batch efficiency for high-throughput hospital needs. Combined with a simplified report format that combines the results of both qPCR and NGS tests, the ...

Ongoing verification study supports compatibility of DeepChek® with the AVITI™ platform. Expands opportunities in ...

If you've ever taken an at-home diagnostic test for COVID-19, you can partially credit the technology to the Johns Hopkins University Center for Innovative Diagnostics for Infectious Diseases (CIDID).

A key microbial genome database is being updated and expanded through a public-private partnership, as the US Food and Drug Administration (FDA) works with a health data company and an academic ...

Oct 3 (Reuters) - The World Health Organization authorized Abbott Laboratories' (ABT.N), opens new tab mpox diagnostic test for emergency use on Thursday, the first such approval in the agency's ...

ABL Diagnostics (FR001400AHX6 – “ABLD”), a specialist in molecular technologies, bioinformatics and decision-support solutions for infectious diseases, announces the presentation of three scientific ...

U.S. Market Valued at USD 2.17 Billion in 2025 While Europe Reaches USD 1.47 Billion as Biomarker-Based Cancer Testing Expands.Austin, United States, June 08, 2026 (GLOBE NEWSWIRE) -- “The Oncology ...

The FDA approved the Oncomine Dx Target Test for identifying HER2-mutant NSCLC patients eligible for Hernexeos, an oral tyrosine kinase inhibitor. Hernexeos offers a new treatment option for ...